NOBILI, RITA LUCIA
NOBILI, RITA LUCIA
Dipartimento di Oncologia ed Emato-Oncologia
LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?
2020 E. Taiana, D. Ronchetti, K. Todoerti, L. Nobili, P. Tassone, N. Amodio, A. Neri
Long Non-Coding RNAs in Multiple Myeloma
2018 R. Nobili, D. Ronchetti, L. Agnelli, E. Taiana, C. Vinci, A. Neri
Long non-coding RNAs in B-cell malignancies: a comprehensive overview
2017 L. Nobili, D. Ronchetti, E. Taiana, A. Neri
Long non-coding RNAs in normal and malignant hematopoiesis
2016 L. Nobili, M. Lionetti, A. Neri
Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression
2014 W. Barcellini, F.G. Imperiali, A. Zaninoni, G. Reda, D. Consonni, B. Fattizzo, S. Lonati, L. Nobili, A. Zanella, A. Cortelezzi
The role of notch pathway in multiple myeloma progression toward IL-6 independence
2014 S. Galletti, S. Ravaioli, M. Colombo, S. Garavelli, K. Todoerti, E. Lazzari, N. Platonova, M. Manzoni, L. Nobili, D. Ronchetti, A. Neri, R. Chiaramonte
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line
2014 D. Verdelli, L. Nobili, K. Todoerti, L. Mosca, S. Fabris, M. D'Anca, E. Pellegrino, R. Piva, G. Inghirami, C. Capelli, M. Introna, L. Baldini, R. Chiaramonte, L. Lombardi, A. Neri
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma
2010 M. Lionetti, D. Verdelli, D. Ronchetti, R.L. Nobili, L. Agnelli, L. Lombardi, G. Lambertenghi Deliliers, A. Neri
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma
2010 L. Agnelli, M. Lionetti, D. Verdelli, D. Ronchetti, L. Nobili, L. Lombardi, G. Lambertenghi Deliliers, A. Neri
The clinical and biological features of a series of immunophenotypic variant of B-CLL
2010 L. Cro, A. Ferrario, M. Lionetti, F. Bertoni, N. Zucal, L. Nobili, S. Fabris, K. Todoerti, A. Cortelezzi, A. Guffanti, M. Goldaniga, L. Marcheselli, A. Neri, G. Lambertenghi Deliliers, L. Baldini
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological molecular characterization by a genomic integrative analisys
2009 D. Verdelli, L. Nobili, K. Todoerti, L. Mosca, S. Fabris, G. Lambertenghi Deliliers, L. Lombardi, A. Neri
A novel fish-based normalization procedure for whole genome microarrays detection accurate local copy numbers : application to multiple myeloma
2009 L. Agnelli, L. Mosca, A. Andronache, S. Fabris, M. Lionetti, I. Kwee, K. Todoerti, D. Verdelli, R.L. Nobili, V. Polli, C. Battaglia, F. Bertoni, G. Lambertenghi Deliliers, A. Neri
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological and molecular characterization by a genomic integrative analisys
2009 L. Nobili, D. Verdelli, K. Todoerti, L. Mosca, S. Fabris, S. Leone, G. Lambertenghi Deliliers, L. Lombardi, A. Neri
Establishment of an interlukin-6 independent variant (CMA-03/06) of the human myeloma cell line CMA-03 : biological and molecular characterization by a genomic integrative analisys
2009 D. Verdelli, L. Nobili, K. Todoerti, L. Mosca, S. Fabris, S. Leone, G. Lambertenghi Deliliers, L. Lombardi, A. Neri
ESTABLISHMENT OF AN INTERLEUKIN-6 INDEPENDENT VARIANT (CMA-03/06) OF THE HUMAN MYELOMA CELL LINE CMA-03 : BIOLOGICAL AND MOLECULAR CHARACTERIZATION BY A GENOMIC INTEGRATIVE ANALYSIS
2009 D. Verdelli, R.L. Nobili, K. Todoerti, L. Mosca, S. Fabris, S. Leone, G. LAMBERTENGHI DELILIERS, L. Lombardi, A. Neri
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups
2009 M. Lionetti, L. Agnelli, K. Todoerti, S. Fabris, R.L. Nobili, S. Leone, S. Matis, G. Cutrona, G. Lambertenghi Deliliers, A. Neri
Biological and molecular characterization by integrative genomics approach of CMA-03/06, a newly established interleukin-6 independent variant of the CMA-03 human myeloma cell line
2009 D. Verdelli, L. Nobili, K. Todoerti, L. Mosca, S. Fabris, G. Lambertenghi Deliliers, A. Neri
Clinico-biological characterization of a subset of variant B-CLL, defined according to a combined cytofluorimetric/fish diagnostic approach
2009 A. Ferrario, L. Cro, L. Baldini, N. Zucal, R.L. Nobili, A. Neri, M. Lionetti, S. Fabris, F. Bertoni, F. Morabito, G. Cutrona, A. Cortelezzi, A. Guffanti, M. Goldaniga, L. Marcheselli, M. Ferrarini, G. Lambertenghi Deliliers
Global microrna expression profiling in multiple myeloma identifies deregulated patterns associated with distinct molecular groups
2009 M. Lionetti, L. Agnelli, M. Biasiolo, S. Fabris, S. Bicciato, K. Todoerti, L. Mosca, R.L. Nobili, S. Leone, S. Matis, S. Bortoluzzi, G. Lambertenghi Deliliers, A. Neri
Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression
2009 D. Verdelli, L. Nobili, K. Todoerti, D. Intini, M. Cosenza, M. Civallero, J. Bertacchini, G. Lambertenghi Deliliers, S. Sacchi, L. Lombardi, A. Neri